Mirae Asset Global Investments
ROIV icon

Mirae Asset Global Investments’s Roivant Sciences ROIV Stock Holding History

Mirae Asset Global Investments’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Sell
34,239
-4,883
-12% -$144K ﹤0.01% 861
2026
Q1 		$1.08M Buy
39,122
+3,629
+10% +$93.2K ﹤0.01% 834
2025
Q4 		$770K Buy
35,493
+9,093
+34% +$179K ﹤0.01% 934
2025
Q3 		$399K Buy
26,400
+139
+0.5% +$1.72K ﹤0.01% 1021
2025
Q2 		$296K Buy
26,261
+2,385
+10% +$25.9K ﹤0.01% 1008
2025
Q1 		$248K Sell
23,876
-382
-2% -$4.13K ﹤0.01% 1015
2024
Q4 		$286K Sell
24,258
-2,489
-9% -$29.4K ﹤0.01% 1010
2024
Q3 		$307K Buy
26,747
+4,692
+21% +$53.4K ﹤0.01% 1019
2024
Q2 		$233K Sell
22,055
-27,807
-56% -$305K ﹤0.01% 1027
2024
Q1 		$526K Sell
49,862
-1,308
-3% -$14.1K ﹤0.01% 1870
2023
Q4 		$575K Buy
51,170
+10,319
+25% +$101K ﹤0.01% 1899
2023
Q3 		$477K Sell
40,851
-929
-2% -$10.5K ﹤0.01% 1912
2023
Q2 		$417K Sell
41,780
-5,187
-11% -$46.4K ﹤0.01% 2023
2023
Q1 		$347K Buy
46,967
+28,609
+156% +$236K ﹤0.01% 2098
2022
Q4 		$147K Buy
+18,358
New +$102K ﹤0.01% 2375

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Mirae Asset Global Investments's ROIV Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Roivant Sciences (ROIV) stake by 12% in Q2 2026, selling an estimated $144K and leaving 34,239 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #861.

Mirae Asset Global Investments first reported a position in ROIV in Q4 2022 and has held it in 15 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Mirae Asset Global Investments held 34,239 shares of Roivant Sciences worth $1.21M as of Q2 2026.
  • Mirae Asset Global Investments sold 4,883 Roivant Sciences shares in Q2 2026, an estimated $144K.
  • Roivant Sciences made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #861 holding.
  • Mirae Asset Global Investments first reported a position in Roivant Sciences in Q4 2022 and has held it in 15 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.